BioNeutra Global Corporation ('BioNeutra' or the 'Company') (TSX-V: BGA), is pleased to announce the appointment of Mr. Bill Smith as Chairman of the Board of Directors of BioNeutra Global Corporation effective December 31st , 2019.

Mr. Smith also serves as Senior Vice President of BioNeutra North America Inc. (BNA), a subsidiary of the Company. Mr. Smith is a former three-term Edmonton Mayor and successful businessman, and has served as a director on three public company boards and chaired two. The Company also announces the resignation of Mr. Douglas Horner as a member of the Board of Directors and also as Chairman of the Company for personal reasons effective December 31st , 2019. Mr. Horner says, 'I believe I have added value to the Company, however I believe the team in place will be able to achieve their goals.' Founder, President and CEO Dr. Jianhua Zhu commented, 'Our Company has benefited from Doug's considerable experience. He was able to achieve a number of important objectives during the five months he's been with us and we're grateful for the contributions he's made.'

Dr. Zhu went on to say, 'We're fortunate to have Mr. Bill Smith - another man who also has considerable experience, to help us to continue to grow our company which has become a sector leader and winner of more awards and recognitions in the past three years than any other Canadian company.

About BioNeutra

BioNeutra is in the business of research and development, production and commercialization of ingredients for nutraceutical, functional and mainstream foods and beverages, with a focus on VitaFiber IMOs. The Company's lead product, VitaFiber, is an advanced functional and health food and beverage ingredient scientifically made from natural agricultural products, is generally regarded as safe (GRAS) by the U.S. Food & Drug Administration, and is European Food Safety Authority and Health Canada approved as a novel food ingredient. VitaFiber is naturally sweet and lower in calories than regular sugar and is a natural source of dietary fiber as it provides low calorie soluble prebiotic fiber for human digestive health. The Company produces VitaFiber using its patented processes that naturally transforms starch molecules from agriculture cereal crops including Non-GMO corn, wheat, barley, potato, or tapioca into the functional health molecules of VitaFiber IMO. The VitaFiber manufacturing process is based upon a natural enzymatic conversion of starch molecules without any chemical modification involved, making VitaFiber a natural food and beverage ingredient. VitaFiber is also non-GMO, vegan-friendly, gluten-free, Kosher and Halal certified and available as certified organic. The Company's customers include a mix of small and medium enterprises and a number of high-profile food and beverage manufacturers in Canada, the U.S., Europe, the United Kingdom, and Mexico. VitaFiber is also available for retail purchase across the globe through Amazon.com and other direct-to-consumer retailers.

Contact:

Tel: (780) 466-1481

Email: jianhua.zhu@bioneutra.ca

Forward-Looking Information

This press release may include forward-looking information within the meaning of Canadian securities legislation concerning the business of BioNeutra. Forwardlooking information is based on certain key expectations and assumptions made by the management of BioNeutra. Although BioNeutra believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because BioNeutra can give no assurance that they will prove to be correct. Forward-looking statements contained in this press release are made as of the date of this press release. BioNeutra disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws. This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein in the United States. The securities described herein have not been and will not be registered under the United States Securities Act of 1933, as amended, or any applicable securities laws or any state of the United States and may not be offered or sold in the United States or to the account or benefit of a person in the United States absent an exemption from the registration requirements.

(C) 2019 Electronic News Publishing, source ENP Newswire